These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1774433)

  • 1. Interleukin-1 alpha enhances hepatotoxicity of tumor necrosis factor-alpha in galactosamine-sensitized mice.
    Nagakawa J; Hishinuma I; Hirota K; Miyamoto K; Yasuda M; Yamanaka T; Katayama K
    Immunopharmacol Immunotoxicol; 1991; 13(4):485-98. PubMed ID: 1774433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice.
    Tiegs G; Niehörster M; Wendel A
    Biochem Pharmacol; 1990 Sep; 40(6):1317-22. PubMed ID: 2403385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways.
    Bohlinger I; Leist M; Barsig J; Uhlig S; Tiegs G; Wendel A
    Hepatology; 1995 Dec; 22(6):1829-37. PubMed ID: 7489995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.
    Endo Y; Kikuchi T; Nakamura M
    Br J Pharmacol; 1992 Nov; 107(3):888-94. PubMed ID: 1472981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury.
    Louis H; Le Moine O; Peny MO; Gulbis B; Nisol F; Goldman M; Devière J
    Gastroenterology; 1997 Mar; 112(3):935-42. PubMed ID: 9041256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice.
    Santucci L; Fiorucci S; Chiorean M; Brunori PM; Di Matteo FM; Sidoni A; Migliorati G; Morelli A
    Gastroenterology; 1996 Sep; 111(3):736-44. PubMed ID: 8780580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.
    Furuya S; Kono H; Hara M; Hirayama K; Sun C; Fujii H
    J Surg Res; 2015 Dec; 199(2):487-93. PubMed ID: 26141869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A.
    Küsters S; Gantner F; Künstle G; Tiegs G
    Gastroenterology; 1996 Aug; 111(2):462-71. PubMed ID: 8690213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.
    Görgen I; Hartung T; Leist M; Niehörster M; Tiegs G; Uhlig S; Weitzel F; Wendel A
    J Immunol; 1992 Aug; 149(3):918-24. PubMed ID: 1378868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF tolerance and cytotoxicity in the liver: the role of interleukin-1beta, inducible nitric oxide-synthase and heme oxygenase-1 in D-galactosamine-sensitized mice.
    Sass G; Koerber K; Tiegs G
    Inflamm Res; 2002 May; 51(5):229-35. PubMed ID: 12056510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice?
    Hasunuma R; Maruyama H; Takimoto H; Ryll R; Tanaka S; Kumazawa Y
    J Endotoxin Res; 2002; 8(5):391-8. PubMed ID: 12537698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice.
    Hishinuma I; Nagakawa J; Hirota K; Miyamoto K; Tsukidate K; Yamanaka T; Katayama K; Yamatsu I
    Hepatology; 1990 Nov; 12(5):1187-91. PubMed ID: 2227817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of lipopolysaccharide and D-galactosamine-mediated hepatocellular apoptosis and lethality.
    Oberholzer A; Oberholzer C; Bahjat FR; Edwards CK; Moldawer LL
    J Endotoxin Res; 2001; 7(5):375-80. PubMed ID: 11753206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
    Tiegs G; Wolter M; Wendel A
    Biochem Pharmacol; 1989 Feb; 38(4):627-31. PubMed ID: 2465008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury.
    Yoshida T; Abe K; Ikeda T; Matsushita T; Wake K; Sato T; Sato T; Inoue H
    Eur J Pharmacol; 2007 Dec; 576(1-3):136-42. PubMed ID: 17825282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury.
    Kim WH; Hong F; Radaeva S; Jaruga B; Fan S; Gao B
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G761-8. PubMed ID: 12816762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha-null mice are not resistant to cadmium chloride-induced hepatotoxicity.
    Harstad EB; Klaassen CD
    Toxicol Appl Pharmacol; 2002 Mar; 179(3):155-62. PubMed ID: 11906245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced susceptibility of nonobese diabetic mice to TNF-alpha and D-galactosamine-mediated hepatocellular apoptosis and lethality.
    Bahjat FR; Dharnidharka VR; Fukuzuka K; Morel L; Crawford JM; Clare-Salzler MJ; Moldawer LL
    J Immunol; 2000 Dec; 165(11):6559-67. PubMed ID: 11086099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.
    Mignon A; Rouquet N; Fabre M; Martin S; Pagès JC; Dhainaut JF; Kahn A; Briand P; Joulin V
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1308-15. PubMed ID: 10194182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.